Supporting Families. Saving Lives.
Sign-up for our Enewsletter here.
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Treated With β-Blockers Experiences of athletes with arrhythmogenic cardiac conditions (SADS) in returning to play Diagnosis and management of rare cardiomyopathies in adult and paediatric patients: the ACM Team Brugada Syndrome: State-of-the-Art Review Abstract Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility Use of oral contraceptives in women with congenital long QT syndrome Clinical characteristics and risk stratification of desmoplakin cardiomyopathy EDITORIAL COMMENTARY Oral contraceptives and their effect on arrhythmogenesis in long QT syndrome: Does it matter? Genome Sequencing in a Genetically Elusive Multi-Generational Long QT Syndrome Pedigree Identifies a Novel LQT2-Causative Deeply Intronic KCNH2 Variant Diagnostic accuracy of the 12-lead ECG in the first 48 hours of life for newborns of a parent with congenital long QT syndrome Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes in to clinical care Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing
An International Multicenter Study on β-Blockers for the Treatment of Symptomatic Children with CPVT
An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis
An autoantibody profile detects Brugada syndrome and identifies abnormally expressedmyocardial proteins